Luca Sforzini, Moira Marizzoni, Chiara Bottanelli, Veronika Kunšteková, Valentina Zonca, Samantha Saleri, Melisa Kose, Giulia Lombardo, Nicole Mariani, Maria A Nettis, Naghmeh Nikkheslat, Courtney Worrell, Zuzanna Zajkowska, Linda Pointon, Philip J Cowen, Jonathan Cavanagh, Neil A Harrison, Marco A Riva, Valeria Mondelli, Edward T Bullmore, Annamaria Cattaneo, Carmine M Pariante
Transcriptomic profiles are important indicators for molecular mechanisms and pathways involved in major depressive disorder (MDD) and its different phenotypes, such as immunometabolic depression. We performed whole-transcriptome and pathway analyses on 139 individuals from the observational, case-control, BIOmarkers in DEPression (BIODEP) study, 105 with MDD and 34 controls. We divided MDD participants based on levels of inflammation, as measured by serum high-sensitivity C-reactive protein (CRP), in n = 39 'not inflamed' (CRP < 1 mg/L), n = 31 with 'elevated CRP' (1-3 mg/L), and n = 35 with 'low-grade inflammation' (>3 mg/L)...
September 13, 2024: Molecular Psychiatry